Inovio Pharmaceuticals, Inc.

Healthcare · Biotechnology · United States

Last price 0.6024 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 62.29M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses SynCon, to help engineer precisely designed plasmid DNA plasmids, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. The company’s lead product candidate is INO-3107 for HPV-related recurrent respiratory papillomatosis and i...